- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
弱势下跌过程中，可逢高卖出，暂不考虑买进。
- 中期趋势：
-
- 长期趋势：
已有49家主力机构披露2024-06-30报告期持股数据，持仓量总计2291.66万股，占流通A股20.89%
- 波段诊断：
-
技术面诊股
诊断结果：2.6技术面打败了35%的股票
技术面评分前10的股票
近期的平均成本为11.49元。
平均成本
近期的平均成本为11.49元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"11.49","date":1732178856,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势接近大盘，跑输行业平均水平。
[{"date":"2024.11.22","stock":"-3.94","trade":"-4.07","ind":"-3.52"},{"date":"2024.11.21","stock":"0.43","trade":"-0.18","ind":"-0.07"},{"date":"2024.11.20","stock":"2.38","trade":"2.34","ind":"0.78"},{"date":"2024.11.19","stock":"1.79","trade":"0.64","ind":"1.90"},{"date":"2024.11.18","stock":"-2.62","trade":"-0.65","ind":"-1.91"},{"date":"2024.11.15","stock":"-2.05","trade":"-2.29","ind":"-2.62"},{"date":"2024.11.14","stock":"-4.02","trade":"-3.87","ind":"-2.83"},{"date":"2024.11.13","stock":"-3.18","trade":"-1.73","ind":"0.40"},{"date":"2024.11.12","stock":"3.20","trade":"5.16","ind":"-0.65"},{"date":"2024.11.11","stock":"0.25","trade":"0.99","ind":"2.03"},{"date":"2024.11.08","stock":"-1.14","trade":"-1.13","ind":"-0.66"},{"date":"2024.11.07","stock":"2.76","trade":"2.85","ind":"2.44"},{"date":"2024.11.06","stock":"0.67","trade":"0.28","ind":"-0.35"},{"date":"2024.11.05","stock":"2.59","trade":"1.11","ind":"3.22"},{"date":"2024.11.04","stock":"-0.60","trade":"2.16","ind":"1.99"},{"date":"2024.11.01","stock":"1.13","trade":"3.44","ind":"-1.28"},{"date":"2024.10.31","stock":"-1.20","trade":"0.60","ind":"0.57"},{"date":"2024.10.30","stock":"-2.26","trade":"-0.40","ind":"-0.12"},{"date":"2024.10.29","stock":"-2.13","trade":"-2.99","ind":"-1.33"},{"date":"2024.10.28","stock":"-0.81","trade":"2.25","ind":"0.62"},{"date":"2024.10.25","stock":"4.86","trade":"1.75","ind":"1.71"}]
达嘉维康,深证成指,医药商业指数
压力支撑
该股压力位为11.41元，支撑位为11.10元。
[{"text":"\u538b\u529b\u4f4d","value":"11.41","date":1732204800,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"11.10","date":1732204800,"color":"0x0b52a1"}]
多空趋势
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：3.2资金面打败了41%的股票
主力控盘前10的股票
行业资金
医药商业行业， 近5日资金流出较多，不建议投资者关注该行业的个股。
更新时间：11月22日 17:48
| 机构今日流向(万元) | -3793.62 | 机构5日流向(万元) | -5417.89 |
| 机构10日流向(万元) | -20931.08 | 机构20日流向(万元) | -32398.34 |
机构持仓
2024-06-30 与 2023-12-31 相比，主力机构持仓量增加23.70万股，其中基金净减仓5家，主力净减仓13家，暂未发现中长期投资价值。
截止2024-06-30，共49家主力机构（基金43家，一般法人4家，券商1家，QFII1家），持仓量总计2291.66万股，占流通A股20.89%
其中，基金持仓与2023-12-31相比：
增仓：2家 ，增持 1.19万股
减仓：7家 ，减持 11.14万股
新出现在主力名单中：16家 ，持有112.34万股
从主力名单中消失：29家 ，原持有68.72万股
其中，基金持仓与2023-12-31相比：
增仓：2家 ，增持 1.19万股
减仓：7家 ，减持 11.14万股
新出现在主力名单中：16家 ，持有112.34万股
从主力名单中消失：29家 ，原持有68.72万股
消息面诊股
诊断结果：5.5消息面打败了46%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- 达嘉维康：11月21日获融资买入308.06万元，
2024-11-22 - 第89届全国药品交易会召开，这些国内药企的展品吸睛
2024-11-21 - 达嘉维康：11月20日获融资买入390.01万元，
2024-11-21 - 达嘉维康：11月19日获融资买入308.58万元，
2024-11-20 - 达嘉维康：正积极研究论证AI在医疗领域的应用契合度
2024-11-15 - 达嘉维康：公司对人工智能在医疗领域的应用前景和进展
2024-11-15 - 达嘉维康：11月13日获融资买入1439.21万元
2024-11-14 - 达嘉维康：11月12日获融资买入3072.40万元
2024-11-13 - 达嘉维康：长沙嘉辰医院现面向全球引进战略资本
2024-11-13 - 达嘉维康：公司成为辉瑞、拜耳、阿斯利康、葛兰素史克
2024-11-13
消息列表
| 一般消息 | 股东大会 | 临时股东大会 | 2024-10-30 |
| 一般消息 | 募资投向 | 2024-09-25 | |
| 一般消息 | 分红转增 | 不分配不转增 | 2024-08-30 |
| 重大利好 | 业绩预告 | 业绩大幅上升 | 2024-07-23 |
| 利好 | 重大事项 | 参股拟上市公司或非上市公司金融机构 | 2024-06-30 |
| 利好 | 分红转增 | 10派0.4元(含税) | 2024-04-23 |
| 一般消息 | 重大事项 | 关联交易 | 2024-04-15 |
| 利好 | 股票增发 | 股东大会通过 | 2024-03-29 |
| 利好 | 重大事项 | 参股拟上市公司或非上市公司金融机构 | 2023-12-31 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 5条 | 1条 | 4条 |
| 利空 | 0条 | 0条 | 0条 |
行业面诊股
诊断结果：2.8行业面打败了33%的股票
医药商业行业最新资金流向
近10日来该行业走势不明显，接近大盘。
行业走势
近10日来该行业走势不明显，接近大盘。
[{"date":"2024.11.22","price":"-3.52","value":"-4.07"},{"date":"2024.11.21","price":"-0.07","value":"-0.18"},{"date":"2024.11.20","price":"0.78","value":"2.34"},{"date":"2024.11.19","price":"1.90","value":"0.64"},{"date":"2024.11.18","price":"-1.91","value":"-0.65"},{"date":"2024.11.15","price":"-2.62","value":"-2.29"},{"date":"2024.11.14","price":"-2.83","value":"-3.87"},{"date":"2024.11.13","price":"0.40","value":"-1.73"},{"date":"2024.11.12","price":"-0.65","value":"5.16"},{"date":"2024.11.11","price":"2.03","value":"0.99"},{"date":"2024.11.08","price":"-0.66","value":"-1.13"},{"date":"2024.11.07","price":"2.44","value":"2.85"},{"date":"2024.11.06","price":"-0.35","value":"0.28"},{"date":"2024.11.05","price":"3.22","value":"1.11"},{"date":"2024.11.04","price":"1.99","value":"2.16"},{"date":"2024.11.01","price":"-1.28","value":"3.44"},{"date":"2024.10.31","price":"0.57","value":"0.60"},{"date":"2024.10.30","price":"-0.12","value":"-0.40"},{"date":"2024.10.29","price":"-1.33","value":"-2.99"},{"date":"2024.10.28","price":"0.62","value":"2.25"},{"date":"2024.10.25","price":"1.71","value":"1.75"}]
深证成指,医药商业行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 健之佳 | 18.88% | 3.73% | 5.0分 |
| 2 | 药易购 | 14.73% | -12.70% | 3.9分 |
| 3 | 塞力医疗 | 13.09% | 0.00% | 4.2分 |
| 4 | 漱玉平民 | 11.73% | -3.61% | 3.8分 |
| 5 | 国药股份 | 10.41% | 2.16% | 5.1分 |
| 6 | 人民同泰 | 10.40% | -2.54% | 4.5分 |
| 8 | 第一医药 | 9.64% | -4.77% | 4.1分 |
| 10 | 嘉事堂 | 6.74% | 2.94% | 4.3分 |
| 12 | 老百姓 | 4.14% | -2.87% | 4.7分 |
| 14 | 上海医药 | 3.68% | 5.34% | 5.7分 |
| 16 | 柳药集团 | 3.39% | 0.33% | 4.6分 |
| 18 | 大参林 | 2.34% | -4.49% | 4.8分 |
| 20 | 合富中国 | 1.45% | -3.85% | 3.8分 |
| 22 | 瑞康医药 | 0.96% | 1.95% | 3.9分 |
| 24 | 浙江震元 | -1.10% | -0.25% | 4.2分 |
| 26 | 一心堂 | -2.09% | -4.57% | 3.9分 |
| 28 | 开开实业 | -6.34% | -5.25% | 4.0分 |
| 30 | 达嘉维康 | -8.86% | -2.10% | 3.9分 |
行业评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 暂无相关评级 |
更多>>行业资讯
- 2012-02-17青岛：加快向“世界强港”转型新增万吨级泊位24个
- 2012-02-17江苏港口发展“四稳四进”
- 2012-02-17今年河北省重点打造综合性港口群
- 2012-02-16招商轮船：非公开发行A股股票申请获得中国证券监督管理委员会核准
- 2012-02-16泉州市今年将冲刺“亿吨大港”
- 2012-02-16大连市集装箱运输生产“逆市飘红”
- 2012-02-16江苏港口发展“四稳四进”
- 2012-02-16连云港港：绿色生态大港正向我们走来
- 2012-02-15靖江今年港口建设预投28亿元 完成港口货物吞吐量8000万吨
- 2012-02-15舟山“大港口”建设撬动群岛新区大盘
基本面诊股
[ 截止日期：2024-09-30 ]公司经营
盈利能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 25/71 ， 12/71。
[{"date":"2024-09-30","value":"2.08","vol":"5.85"},{"date":"2024-06-30","value":"1.81","vol":"4.44"},{"date":"2024-03-31","value":"1.11","vol":"2.30"},{"date":"2023-12-31","value":"1.98","vol":"7.23"},{"date":"2023-09-30","value":"1.38","vol":"7.28"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
2.08 | 1.81 | 1.11 | 1.98 | 1.38 |
| 行业(%) | 5.85 | 4.44 | 2.30 | 7.23 | 7.28 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2024-09-30","value":"19.18","vol":"17.89"},{"date":"2024-06-30","value":"19.19","vol":"17.84"},{"date":"2024-03-31","value":"19.24","vol":"17.80"},{"date":"2023-12-31","value":"14.78","vol":"17.83"},{"date":"2023-09-30","value":"13.67","vol":"18.09"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
19.18 | 19.19 | 19.24 | 14.78 | 13.67 |
| 行业(%) | 17.89 | 17.84 | 17.80 | 17.83 | 18.09 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 1/71 ， 4/71。
[{"date":"2024-09-30","value":"43.43","vol":"2.06"},{"date":"2024-06-30","value":"46.95","vol":"1.88"},{"date":"2024-03-31","value":"46.06","vol":"4.80"},{"date":"2023-12-31","value":"18.56","vol":"4.27"},{"date":"2023-09-30","value":"23.99","vol":"6.21"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
43.43 | 46.95 | 46.06 | 18.56 | 23.99 |
| 行业(%) | 2.06 | 1.88 | 4.80 | 4.27 | 6.21 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2024-09-30","value":"53.04","vol":"-50.40"},{"date":"2024-06-30","value":"75.04","vol":"-17.67"},{"date":"2024-03-31","value":"27.14","vol":"3.54"},{"date":"2023-12-31","value":"-32.85","vol":"2.19"},{"date":"2023-09-30","value":"-54.96","vol":"10.40"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
53.04 | 75.04 | 27.14 | -32.85 | -54.96 |
| 行业(%) | -50.40 | -17.67 | 3.54 | 2.19 | 10.40 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 23/71 ， 17/71。
[{"date":"2024-09-30","value":"0.69","vol":"0.89"},{"date":"2024-06-30","value":"0.46","vol":"0.60"},{"date":"2024-03-31","value":"0.23","vol":"0.31"},{"date":"2023-12-31","value":"0.85","vol":"1.24"},{"date":"2023-09-30","value":"0.59","vol":"0.91"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.69 | 0.46 | 0.23 | 0.85 | 0.59 |
| 行业(次) | 0.89 | 0.60 | 0.31 | 1.24 | 0.91 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2024-09-30","value":"4.34","vol":"4.52"},{"date":"2024-06-30","value":"2.87","vol":"3.08"},{"date":"2024-03-31","value":"1.41","vol":"1.58"},{"date":"2023-12-31","value":"6.26","vol":"6.32"},{"date":"2023-09-30","value":"4.42","vol":"4.72"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
4.34 | 2.87 | 1.41 | 6.26 | 4.42 |
| 行业(次) | 4.52 | 3.08 | 1.58 | 6.32 | 4.72 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：数据暂时不全，请后续关注
[{"date":"2024-09-30","value":"-7.36","vol":"4.01"},{"date":"2024-06-30","value":"-3.31","vol":"6.46"},{"date":"2024-03-31","value":"-13.71","vol":"-3.83"},{"date":"2023-12-31","value":"24.61","vol":"10.23"},{"date":"2023-09-30","value":"-9.09","vol":"2.62"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | -7.36 | -3.31 | -13.71 | 24.61 | -9.09 |
| 行业 | 4.01 | 6.46 | -3.83 | 10.23 | 2.62 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2024-09-30","value":"","vol":"0.00"},{"date":"2024-06-30","value":"1.05","vol":"0.77"},{"date":"2024-03-31","value":"","vol":"0.00"},{"date":"2023-12-31","value":"2.28","vol":"1.02"},{"date":"2023-09-30","value":"","vol":"0.00"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | - | 1.05 | - | 2.28 | - |
| 行业 | 0.00 | 0.77 | 0.00 | 1.02 | 0.00 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 20/71 ， 9/71。
[{"date":"2024-09-30","value":"1.27","vol":"1.47"},{"date":"2024-06-30","value":"1.31","vol":"1.49"},{"date":"2024-03-31","value":"1.31","vol":"1.51"},{"date":"2023-12-31","value":"1.30","vol":"1.51"},{"date":"2023-09-30","value":"1.23","vol":"1.48"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 流动比率 |
1.27 | 1.31 | 1.31 | 1.30 | 1.23 |
| 行业 | 1.47 | 1.49 | 1.51 | 1.51 | 1.48 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2024-09-30","value":"0.90","vol":"1.04"},{"date":"2024-06-30","value":"0.94","vol":"1.06"},{"date":"2024-03-31","value":"0.92","vol":"1.09"},{"date":"2023-12-31","value":"0.96","vol":"1.07"},{"date":"2023-09-30","value":"0.91","vol":"1.06"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 速动比率 |
0.90 | 0.94 | 0.92 | 0.96 | 0.91 |
| 行业 | 1.04 | 1.06 | 1.09 | 1.07 | 1.06 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 24/71 ， 10/71。
[{"date":"2024-09-30","value":"70.63","vol":"61.64"},{"date":"2024-06-30","value":"69.84","vol":"61.18"},{"date":"2024-03-31","value":"69.70","vol":"61.00"},{"date":"2023-12-31","value":"66.24","vol":"60.66"},{"date":"2023-09-30","value":"66.95","vol":"61.05"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
70.63 | 69.84 | 69.70 | 66.24 | 66.95 |
| 行业(%) | 61.64 | 61.18 | 61.00 | 60.66 | 61.05 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2024-09-30","value":"2.51","vol":"2.19"},{"date":"2024-06-30","value":"2.41","vol":"2.15"},{"date":"2024-03-31","value":"2.39","vol":"2.15"},{"date":"2023-12-31","value":"2.00","vol":"2.12"},{"date":"2023-09-30","value":"2.10","vol":"2.07"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
2.51 | 2.41 | 2.39 | 2.00 | 2.10 |
| 行业(%) | 2.19 | 2.15 | 2.15 | 2.12 | 2.07 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构预测
暂时还没有机构预测该股2024年的收益，请投资者后续关注。
[{"date":"2020","yellowRectValue":"0.00","blueLineValue":"","type":""},{"date":"2021","yellowRectValue":"0.68","blueLineValue":"","type":""},{"date":"2022","yellowRectValue":"0.51","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"0.34","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"0.00","blueLineValue":"","type":"YC"}]